Employers Face a 9% Healthcare Cost Surge: The Urgency of Rethinking Primary Care

As employers grapple with their 2026 benefits budgets, they are facing a stark reality: healthcare costs are expected to rise by about 9% next year, building on last year's increases. For HR leaders already dealing with wage pressures, retention issues, and economic uncertainty, the annual renewal cycle has become an all-too-familiar exercise in either absorbing higher costs or passing them along to employees.

But this year feels different. The cost landscape is shifting more dramatically than ever before, driven by a surge in specialty drug spending, particularly GLP-1 medications for diabetes and obesity, and a growing reliance on high-cost specialty care. Chronic diseases continue to be the biggest driver of long-term claims volatility, pushing employers to confront not just incremental inflation but unprecedented structural cost growth.

The GLP-1 Effect and the Specialty Spiral

GLP-1 medications have revolutionized the treatment of diabetes and obesity, offering life-changing benefits for many patients. However, these drugs come with a hefty price tag-often thousands of dollars per member per year. For employers, this rapid expansion in specialty drug spending represents a significant financial burden.

Without coordinated oversight, the use of GLP-1 medications can become reactive rather than proactive. Patients may receive medication without adequate behavioral support, nutritional counseling, or long-term management. This can lead to high discontinuation rates, weight regain, and ongoing healthcare costs. The issue is compounded by the broader trend of increasing specialty drug spending, which is growing faster than traditional pharmacy costs.

Referrals to high-cost specialists continue to rise, and emergency department visits remain elevated, even when many of these cases could be managed in lower-acuity settings. These trends highlight a critical underlying issue: fragmented primary care.

The Throughput Problem in Primary Care

Today's primary care physicians (PCPs) are often compensated based on the number of patients they see, rather than the quality of care they provide. This volume-based model can lead to rushed appointments and limited time for comprehensive patient management. As a result, PCPs may not have the resources or incentives to coordinate care effectively, leading to more referrals to specialists and higher overall healthcare costs.

To address this issue, employers need to rethink their approach to primary care. Investing in models that prioritize quality over quantity can lead to better health outcomes and lower long-term costs. This might include value-based care arrangements, where providers are rewarded for keeping patients healthy rather than just treating them when they fall ill.

Integrating behavioral health services and nutritional counseling into primary care can help manage chronic conditions more effectively. By providing holistic support, employers can reduce the need for expensive specialty drugs and specialist referrals, ultimately lowering healthcare costs while improving patient well-being.

Why It Matters

The rising cost of healthcare is not just a financial issue; it has real-world implications for employees and their families. High healthcare costs can lead to reduced take-home pay, increased financial stress, and decreased job satisfaction. By addressing the root causes of these cost increases-such as fragmented primary care and the overuse of specialty drugs-employers can create a more sustainable and equitable healthcare system.

Ultimately, a proactive approach to managing healthcare costs can benefit both employers and employees. By investing in quality primary care and comprehensive health management, employers can foster a healthier workforce, improve productivity, and ensure that their benefits programs remain viable for years to come.